首页> 外文会议>International photodynamic association biennial meeting >Serum levels of hematoporphyrin derivatives in the photodynamic therapy of malignant tumors
【24h】

Serum levels of hematoporphyrin derivatives in the photodynamic therapy of malignant tumors

机译:恶性肿瘤光动力疗法中血清血清水平的血清卟啉衍生物

获取原文

摘要

In photodynamic therapy (PDT), red light is administered 24 - 72 hours post intravenous (i.v.) injection of hematoporphyrin derivatives (HpD). In an earlier animal model study, more effective therapeutic response was obtained when red light irradiation was carried out 15 mins after the injection of HpD. The effectiveness of this immediate PDT protocol has been correlated to the high serum level of HpD immediately after administration and the destruction of the microcirculation system as the dominant tumor destruction mechanism. This study examines the pharmacokinetics and the serum levels of HpD in rats and also in human patients. Such data can assist in defining the optimum time delay for light irradiation in the PDT of cancer.
机译:在光动力疗法(PDT)中,静脉注射静脉内(I.V.)施用血液卟啉衍生物(HPD)的24-72小时。在早期的动物模型研究中,当在注射HPD后进行红光照射15分钟时获得更有效的治疗反应。该直接PDT方案的有效性与在给药后立即与高血清HPD的高血清水平相关,并将微循环系统破坏作为显性肿瘤破坏机制。本研究检测药代动力学和大鼠HPD的血清水平以及人类患者。这些数据可以有助于确定癌症PDT中光照射的最佳时间延迟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号